128 related articles for article (PubMed ID: 11425577)
1. Molecular modeling, structure--activity relationships and functional antagonism studies of 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketones as a novel class of dopamine transporter inhibitors.
Wang S; Sakamuri S; Enyedy IJ; Kozikowski AP; Zaman WA; Johnson KM
Bioorg Med Chem; 2001 Jul; 9(7):1753-64. PubMed ID: 11425577
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies.
Wang S; Sakamuri S; Enyedy IJ; Kozikowski AP; Deschaux O; Bandyopadhyay BC; Tella SR; Zaman WA; Johnson KM
J Med Chem; 2000 Feb; 43(3):351-60. PubMed ID: 10669562
[TBL] [Abstract][Full Text] [Related]
3. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
[TBL] [Abstract][Full Text] [Related]
4. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
[TBL] [Abstract][Full Text] [Related]
6. Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.
Hoepping A; Johnson KM; George C; Flippen-Anderson J; Kozikowski AP
J Med Chem; 2000 May; 43(10):2064-71. PubMed ID: 10821718
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
[TBL] [Abstract][Full Text] [Related]
8. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
9. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors.
Tamiz AP; Bandyopadhyay BC; Zhang J; Flippen-Anderson JL; Zhang M; Wang CZ; Johnson KM; Tella S; Kozikowski AP
J Med Chem; 2001 May; 44(10):1615-22. PubMed ID: 11334571
[TBL] [Abstract][Full Text] [Related]
11. 2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitors.
Sakamuri S; Enyedy IJ; Zaman WA; Tella SR; Kozikowski AP; Flippen-Anderson JL; Farkas T; Johnson KM; Wang S
Bioorg Med Chem; 2003 Mar; 11(6):1123-36. PubMed ID: 12614900
[TBL] [Abstract][Full Text] [Related]
12. SAR studies of piperidine-based analogues of cocaine. 4. Effect of N-modification and ester replacement.
Petukhov PA; Zhang J; Kozikowski AP; Wang CZ; Ye YP; Johnson KM; Tella SR
J Med Chem; 2002 Jul; 45(15):3161-70. PubMed ID: 12109901
[TBL] [Abstract][Full Text] [Related]
13. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Dutta AK; Xu C; Reith ME
J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-based discovery, synthesis, and biological evaluation of 4-phenyl-1-arylalkyl piperidines as dopamine transporter inhibitors.
Sakamuri S; Enyedy IJ; Kozikowski AP; Zaman WA; Johnson KM; Wang S
Bioorg Med Chem Lett; 2001 Feb; 11(4):495-500. PubMed ID: 11229756
[TBL] [Abstract][Full Text] [Related]
15. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
Husbands SM; Izenwasser S; Kopajtic T; Bowen WD; Vilner BJ; Katz JL; Newman AH
J Med Chem; 1999 Oct; 42(21):4446-55. PubMed ID: 10543888
[TBL] [Abstract][Full Text] [Related]
17. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label.
Dutta AK; Fei XS; Vaughan RA; Gaffaney JD; Wang N; Lever JR; Reith ME
Life Sci; 2001 Mar; 68(16):1839-49. PubMed ID: 11292062
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).
Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC
J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]